nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—PTGS2—pancreatic cancer	0.24	1	CbGaD
Dapsone—FMO3—Tamoxifen—pancreatic cancer	0.216	0.327	CbGbCtD
Dapsone—CYP2E1—Dacarbazine—pancreatic cancer	0.0352	0.0532	CbGbCtD
Dapsone—CYP3A7—Tamoxifen—pancreatic cancer	0.029	0.0439	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.029	0.0439	CbGbCtD
Dapsone—MPO—superior mesenteric artery—pancreatic cancer	0.0288	0.743	CbGeAlD
Dapsone—CYP2E1—Tamoxifen—pancreatic cancer	0.028	0.0424	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0223	0.0337	CbGbCtD
Dapsone—CYP3A7—Irinotecan—pancreatic cancer	0.0223	0.0337	CbGbCtD
Dapsone—CYP3A5—Tamoxifen—pancreatic cancer	0.0217	0.0329	CbGbCtD
Dapsone—CYP2C8—Tamoxifen—pancreatic cancer	0.0209	0.0316	CbGbCtD
Dapsone—CYP3A5—Erlotinib—pancreatic cancer	0.0185	0.028	CbGbCtD
Dapsone—CYP2C8—Erlotinib—pancreatic cancer	0.0178	0.0269	CbGbCtD
Dapsone—CYP2C19—Tamoxifen—pancreatic cancer	0.0175	0.0265	CbGbCtD
Dapsone—CYP3A5—Irinotecan—pancreatic cancer	0.0167	0.0253	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0163	0.0247	CbGbCtD
Dapsone—CYP3A7—Docetaxel—pancreatic cancer	0.0163	0.0247	CbGbCtD
Dapsone—CYP3A7—Sunitinib—pancreatic cancer	0.0162	0.0246	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0162	0.0246	CbGbCtD
Dapsone—CYP2C8—Fluorouracil—pancreatic cancer	0.0154	0.0233	CbGbCtD
Dapsone—CYP2C9—Tamoxifen—pancreatic cancer	0.0146	0.0221	CbGbCtD
Dapsone—CYP3A5—Docetaxel—pancreatic cancer	0.0122	0.0185	CbGbCtD
Dapsone—CYP3A5—Sunitinib—pancreatic cancer	0.0122	0.0184	CbGbCtD
Dapsone—CYP2C9—Fluorouracil—pancreatic cancer	0.0107	0.0163	CbGbCtD
Dapsone—CYP3A4—Tamoxifen—pancreatic cancer	0.00848	0.0128	CbGbCtD
Dapsone—CYP3A4—Erlotinib—pancreatic cancer	0.00721	0.0109	CbGbCtD
Dapsone—CYP3A4—Irinotecan—pancreatic cancer	0.00651	0.00985	CbGbCtD
Dapsone—CYP3A4—Docetaxel—pancreatic cancer	0.00477	0.00722	CbGbCtD
Dapsone—CYP3A4—Sunitinib—pancreatic cancer	0.00475	0.00719	CbGbCtD
Dapsone—Hypoalbuminaemia—Sunitinib—pancreatic cancer	0.00452	0.0747	CcSEcCtD
Dapsone—Application site burn—Fluorouracil—pancreatic cancer	0.00371	0.0614	CcSEcCtD
Dapsone—CYP3A4—Doxorubicin—pancreatic cancer	0.00356	0.00538	CbGbCtD
Dapsone—Nephrotic syndrome—Sunitinib—pancreatic cancer	0.00204	0.0337	CcSEcCtD
Dapsone—Application site pain—Fluorouracil—pancreatic cancer	0.00177	0.0292	CcSEcCtD
Dapsone—Application site reaction—Fluorouracil—pancreatic cancer	0.00166	0.0274	CcSEcCtD
Dapsone—CYP2C18—digestive system—pancreatic cancer	0.0014	0.0361	CbGeAlD
Dapsone—Proteinuria—Erlotinib—pancreatic cancer	0.0013	0.0214	CcSEcCtD
Dapsone—Protein urine present—Erlotinib—pancreatic cancer	0.00128	0.0211	CcSEcCtD
Dapsone—Proteinuria—Sunitinib—pancreatic cancer	0.00112	0.0186	CcSEcCtD
Dapsone—Protein urine present—Sunitinib—pancreatic cancer	0.00111	0.0183	CcSEcCtD
Dapsone—Skin exfoliation—Tamoxifen—pancreatic cancer	0.0011	0.0182	CcSEcCtD
Dapsone—Skin exfoliation—Erlotinib—pancreatic cancer	0.00109	0.018	CcSEcCtD
Dapsone—MPO—pancreas—pancreatic cancer	0.00104	0.0268	CbGeAlD
Dapsone—PTGS2—gall bladder—pancreatic cancer	0.00103	0.0264	CbGeAlD
Dapsone—Skin exfoliation—Sunitinib—pancreatic cancer	0.000942	0.0156	CcSEcCtD
Dapsone—Proteinuria—Gemcitabine—pancreatic cancer	0.000901	0.0149	CcSEcCtD
Dapsone—MPO—digestive system—pancreatic cancer	0.00089	0.0229	CbGeAlD
Dapsone—Protein urine present—Gemcitabine—pancreatic cancer	0.000888	0.0147	CcSEcCtD
Dapsone—CYP3A5—islet of Langerhans—pancreatic cancer	0.000782	0.0202	CbGeAlD
Dapsone—Skin exfoliation—Gemcitabine—pancreatic cancer	0.000756	0.0125	CcSEcCtD
Dapsone—Influenza—Tamoxifen—pancreatic cancer	0.000723	0.0119	CcSEcCtD
Dapsone—Pancreatitis—Tamoxifen—pancreatic cancer	0.000709	0.0117	CcSEcCtD
Dapsone—Pancreatitis—Erlotinib—pancreatic cancer	0.000701	0.0116	CcSEcCtD
Dapsone—PTGS2—islet of Langerhans—pancreatic cancer	0.000672	0.0173	CbGeAlD
Dapsone—Nasopharyngitis—Sunitinib—pancreatic cancer	0.00064	0.0106	CcSEcCtD
Dapsone—Muscular weakness—Sunitinib—pancreatic cancer	0.000632	0.0104	CcSEcCtD
Dapsone—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.000625	0.0103	CcSEcCtD
Dapsone—Pancreatitis—Sunitinib—pancreatic cancer	0.000607	0.01	CcSEcCtD
Dapsone—Sinusitis—Tamoxifen—pancreatic cancer	0.000605	0.00999	CcSEcCtD
Dapsone—CYP2C19—digestive system—pancreatic cancer	0.000596	0.0154	CbGeAlD
Dapsone—Pharyngitis—Tamoxifen—pancreatic cancer	0.000574	0.00949	CcSEcCtD
Dapsone—CYP3A5—pancreas—pancreatic cancer	0.00055	0.0142	CbGeAlD
Dapsone—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.000541	0.00894	CcSEcCtD
Dapsone—Skin exfoliation—Docetaxel—pancreatic cancer	0.000536	0.00886	CcSEcCtD
Dapsone—Albuminuria—Epirubicin—pancreatic cancer	0.000508	0.00839	CcSEcCtD
Dapsone—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.000505	0.00835	CcSEcCtD
Dapsone—Erythema—Tamoxifen—pancreatic cancer	0.000504	0.00832	CcSEcCtD
Dapsone—Pancreatitis—Irinotecan—pancreatic cancer	0.0005	0.00826	CcSEcCtD
Dapsone—Muscular weakness—Fluorouracil—pancreatic cancer	0.000498	0.00823	CcSEcCtD
Dapsone—Erythema—Erlotinib—pancreatic cancer	0.000498	0.00823	CcSEcCtD
Dapsone—Influenza—Gemcitabine—pancreatic cancer	0.000497	0.00821	CcSEcCtD
Dapsone—PTGS2—pancreas—pancreatic cancer	0.000472	0.0122	CbGeAlD
Dapsone—CYP3A5—digestive system—pancreatic cancer	0.00047	0.0121	CbGeAlD
Dapsone—Albuminuria—Doxorubicin—pancreatic cancer	0.00047	0.00776	CcSEcCtD
Dapsone—CYP2C9—digestive system—pancreatic cancer	0.000462	0.0119	CbGeAlD
Dapsone—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.000446	0.00737	CcSEcCtD
Dapsone—Cough—Tamoxifen—pancreatic cancer	0.000439	0.00726	CcSEcCtD
Dapsone—CYP2E1—digestive system—pancreatic cancer	0.000438	0.0113	CbGeAlD
Dapsone—Cough—Erlotinib—pancreatic cancer	0.000435	0.00718	CcSEcCtD
Dapsone—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.000434	0.00717	CcSEcCtD
Dapsone—Erythema—Sunitinib—pancreatic cancer	0.000431	0.00713	CcSEcCtD
Dapsone—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.000427	0.00705	CcSEcCtD
Dapsone—PTGS1—digestive system—pancreatic cancer	0.000422	0.0109	CbGeAlD
Dapsone—Sinusitis—Fluorouracil—pancreatic cancer	0.000408	0.00675	CcSEcCtD
Dapsone—PTGS2—digestive system—pancreatic cancer	0.000403	0.0104	CbGeAlD
Dapsone—Pharyngitis—Gemcitabine—pancreatic cancer	0.000395	0.00652	CcSEcCtD
Dapsone—Pharyngitis—Fluorouracil—pancreatic cancer	0.000388	0.00641	CcSEcCtD
Dapsone—Cough—Sunitinib—pancreatic cancer	0.000376	0.00622	CcSEcCtD
Dapsone—Insomnia—Tamoxifen—pancreatic cancer	0.000372	0.00614	CcSEcCtD
Dapsone—Insomnia—Erlotinib—pancreatic cancer	0.000368	0.00608	CcSEcCtD
Dapsone—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000365	0.00603	CcSEcCtD
Dapsone—Skin exfoliation—Epirubicin—pancreatic cancer	0.000362	0.00598	CcSEcCtD
Dapsone—CYP3A4—digestive system—pancreatic cancer	0.000353	0.00908	CbGeAlD
Dapsone—Erythema—Gemcitabine—pancreatic cancer	0.000346	0.00572	CcSEcCtD
Dapsone—Erythema—Fluorouracil—pancreatic cancer	0.00034	0.00562	CcSEcCtD
Dapsone—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000336	0.00555	CcSEcCtD
Dapsone—Skin exfoliation—Doxorubicin—pancreatic cancer	0.000335	0.00553	CcSEcCtD
Dapsone—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000332	0.00549	CcSEcCtD
Dapsone—Abdominal pain—Tamoxifen—pancreatic cancer	0.000325	0.00537	CcSEcCtD
Dapsone—Abdominal pain—Erlotinib—pancreatic cancer	0.000321	0.00531	CcSEcCtD
Dapsone—Body temperature increased—Erlotinib—pancreatic cancer	0.000321	0.00531	CcSEcCtD
Dapsone—Vision blurred—Fluorouracil—pancreatic cancer	0.000321	0.0053	CcSEcCtD
Dapsone—Vertigo—Irinotecan—pancreatic cancer	0.000319	0.00527	CcSEcCtD
Dapsone—Insomnia—Sunitinib—pancreatic cancer	0.000318	0.00526	CcSEcCtD
Dapsone—Cough—Irinotecan—pancreatic cancer	0.00031	0.00512	CcSEcCtD
Dapsone—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000308	0.00509	CcSEcCtD
Dapsone—Cough—Gemcitabine—pancreatic cancer	0.000302	0.00499	CcSEcCtD
Dapsone—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000288	0.00476	CcSEcCtD
Dapsone—Pharyngitis—Docetaxel—pancreatic cancer	0.00028	0.00463	CcSEcCtD
Dapsone—Abdominal pain—Sunitinib—pancreatic cancer	0.000278	0.0046	CcSEcCtD
Dapsone—Body temperature increased—Sunitinib—pancreatic cancer	0.000278	0.0046	CcSEcCtD
Dapsone—Tachycardia—Fluorouracil—pancreatic cancer	0.000271	0.00448	CcSEcCtD
Dapsone—Insomnia—Irinotecan—pancreatic cancer	0.000262	0.00433	CcSEcCtD
Dapsone—Vomiting—Tamoxifen—pancreatic cancer	0.000261	0.00432	CcSEcCtD
Dapsone—Vomiting—Erlotinib—pancreatic cancer	0.000259	0.00427	CcSEcCtD
Dapsone—Headache—Tamoxifen—pancreatic cancer	0.000257	0.00425	CcSEcCtD
Dapsone—Insomnia—Gemcitabine—pancreatic cancer	0.000255	0.00422	CcSEcCtD
Dapsone—Headache—Erlotinib—pancreatic cancer	0.000255	0.00421	CcSEcCtD
Dapsone—Insomnia—Fluorouracil—pancreatic cancer	0.000251	0.00415	CcSEcCtD
Dapsone—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000246	0.00406	CcSEcCtD
Dapsone—Erythema—Docetaxel—pancreatic cancer	0.000246	0.00406	CcSEcCtD
Dapsone—Nausea—Tamoxifen—pancreatic cancer	0.000244	0.00403	CcSEcCtD
Dapsone—Muscular weakness—Epirubicin—pancreatic cancer	0.000243	0.00401	CcSEcCtD
Dapsone—Nausea—Erlotinib—pancreatic cancer	0.000242	0.00399	CcSEcCtD
Dapsone—Influenza—Epirubicin—pancreatic cancer	0.000238	0.00393	CcSEcCtD
Dapsone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000237	0.00392	CcSEcCtD
Dapsone—Pancreatitis—Epirubicin—pancreatic cancer	0.000233	0.00385	CcSEcCtD
Dapsone—Body temperature increased—Irinotecan—pancreatic cancer	0.000229	0.00379	CcSEcCtD
Dapsone—Abdominal pain—Irinotecan—pancreatic cancer	0.000229	0.00379	CcSEcCtD
Dapsone—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000228	0.00376	CcSEcCtD
Dapsone—Muscular weakness—Doxorubicin—pancreatic cancer	0.000224	0.00371	CcSEcCtD
Dapsone—Vomiting—Sunitinib—pancreatic cancer	0.000224	0.0037	CcSEcCtD
Dapsone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000223	0.00369	CcSEcCtD
Dapsone—Headache—Sunitinib—pancreatic cancer	0.000221	0.00364	CcSEcCtD
Dapsone—Influenza—Doxorubicin—pancreatic cancer	0.00022	0.00364	CcSEcCtD
Dapsone—Body temperature increased—Fluorouracil—pancreatic cancer	0.00022	0.00363	CcSEcCtD
Dapsone—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000217	0.00359	CcSEcCtD
Dapsone—Pancreatitis—Doxorubicin—pancreatic cancer	0.000216	0.00356	CcSEcCtD
Dapsone—Cough—Docetaxel—pancreatic cancer	0.000214	0.00354	CcSEcCtD
Dapsone—Nausea—Sunitinib—pancreatic cancer	0.000209	0.00346	CcSEcCtD
Dapsone—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000208	0.00343	CcSEcCtD
Dapsone—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000201	0.00332	CcSEcCtD
Dapsone—Sinusitis—Epirubicin—pancreatic cancer	0.000199	0.00329	CcSEcCtD
Dapsone—Tachycardia—Docetaxel—pancreatic cancer	0.000196	0.00323	CcSEcCtD
Dapsone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000192	0.00318	CcSEcCtD
Dapsone—Pharyngitis—Epirubicin—pancreatic cancer	0.000189	0.00312	CcSEcCtD
Dapsone—Vomiting—Irinotecan—pancreatic cancer	0.000184	0.00305	CcSEcCtD
Dapsone—Sinusitis—Doxorubicin—pancreatic cancer	0.000184	0.00304	CcSEcCtD
Dapsone—Headache—Irinotecan—pancreatic cancer	0.000182	0.003	CcSEcCtD
Dapsone—Insomnia—Docetaxel—pancreatic cancer	0.000181	0.003	CcSEcCtD
Dapsone—Vomiting—Gemcitabine—pancreatic cancer	0.00018	0.00297	CcSEcCtD
Dapsone—Tinnitus—Epirubicin—pancreatic cancer	0.000177	0.00293	CcSEcCtD
Dapsone—Headache—Gemcitabine—pancreatic cancer	0.000177	0.00292	CcSEcCtD
Dapsone—Vomiting—Fluorouracil—pancreatic cancer	0.000177	0.00292	CcSEcCtD
Dapsone—Pharyngitis—Doxorubicin—pancreatic cancer	0.000175	0.00289	CcSEcCtD
Dapsone—Headache—Fluorouracil—pancreatic cancer	0.000174	0.00287	CcSEcCtD
Dapsone—Nausea—Irinotecan—pancreatic cancer	0.000172	0.00285	CcSEcCtD
Dapsone—Nausea—Gemcitabine—pancreatic cancer	0.000168	0.00277	CcSEcCtD
Dapsone—Erythema—Epirubicin—pancreatic cancer	0.000166	0.00274	CcSEcCtD
Dapsone—Nausea—Fluorouracil—pancreatic cancer	0.000165	0.00273	CcSEcCtD
Dapsone—Tinnitus—Doxorubicin—pancreatic cancer	0.000164	0.00271	CcSEcCtD
Dapsone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000164	0.00271	CcSEcCtD
Dapsone—Abdominal pain—Docetaxel—pancreatic cancer	0.000158	0.00262	CcSEcCtD
Dapsone—Body temperature increased—Docetaxel—pancreatic cancer	0.000158	0.00262	CcSEcCtD
Dapsone—Vision blurred—Epirubicin—pancreatic cancer	0.000156	0.00258	CcSEcCtD
Dapsone—Erythema—Doxorubicin—pancreatic cancer	0.000153	0.00253	CcSEcCtD
Dapsone—Vertigo—Epirubicin—pancreatic cancer	0.000149	0.00246	CcSEcCtD
Dapsone—Cough—Epirubicin—pancreatic cancer	0.000145	0.00239	CcSEcCtD
Dapsone—Vision blurred—Doxorubicin—pancreatic cancer	0.000144	0.00239	CcSEcCtD
Dapsone—Vertigo—Doxorubicin—pancreatic cancer	0.000138	0.00228	CcSEcCtD
Dapsone—Cough—Doxorubicin—pancreatic cancer	0.000134	0.00221	CcSEcCtD
Dapsone—Tachycardia—Epirubicin—pancreatic cancer	0.000132	0.00218	CcSEcCtD
Dapsone—Vomiting—Docetaxel—pancreatic cancer	0.000127	0.00211	CcSEcCtD
Dapsone—Headache—Docetaxel—pancreatic cancer	0.000126	0.00207	CcSEcCtD
Dapsone—Insomnia—Epirubicin—pancreatic cancer	0.000122	0.00202	CcSEcCtD
Dapsone—Tachycardia—Doxorubicin—pancreatic cancer	0.000122	0.00202	CcSEcCtD
Dapsone—Nausea—Docetaxel—pancreatic cancer	0.000119	0.00197	CcSEcCtD
Dapsone—Insomnia—Doxorubicin—pancreatic cancer	0.000113	0.00187	CcSEcCtD
Dapsone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000111	0.00183	CcSEcCtD
Dapsone—Body temperature increased—Epirubicin—pancreatic cancer	0.000107	0.00177	CcSEcCtD
Dapsone—Abdominal pain—Epirubicin—pancreatic cancer	0.000107	0.00177	CcSEcCtD
Dapsone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000102	0.00169	CcSEcCtD
Dapsone—Body temperature increased—Doxorubicin—pancreatic cancer	9.89e-05	0.00163	CcSEcCtD
Dapsone—Abdominal pain—Doxorubicin—pancreatic cancer	9.89e-05	0.00163	CcSEcCtD
Dapsone—Vomiting—Epirubicin—pancreatic cancer	8.6e-05	0.00142	CcSEcCtD
Dapsone—Headache—Epirubicin—pancreatic cancer	8.47e-05	0.0014	CcSEcCtD
Dapsone—Nausea—Epirubicin—pancreatic cancer	8.03e-05	0.00133	CcSEcCtD
Dapsone—Vomiting—Doxorubicin—pancreatic cancer	7.95e-05	0.00131	CcSEcCtD
Dapsone—Headache—Doxorubicin—pancreatic cancer	7.84e-05	0.00129	CcSEcCtD
Dapsone—Nausea—Doxorubicin—pancreatic cancer	7.43e-05	0.00123	CcSEcCtD
